KronosMD Inc CEO to attend the Annual Roth Investor Conference on March 13-14, 2023.
KronosMD (OTC: KNOS) announced that CEO Dr. Greg Rubin will attend the Roth Investor Conference on March 13-14, 2023, to engage with investors, investment bankers, and industry leaders. Attendees can schedule meetings with Dr. Rubin to discuss capital provisions and learn about KronosMD's innovative digital health technology, including the transformative SWAVE™ ultrasound imaging for dental care. This conference is a significant platform for small-cap companies, offering networking and insights into investment opportunities across various sectors.
Investors seeking further details can reach out via KronosMD's investor relations.
- None.
- None.
CEO Dr. Greg Rubin to meet with institutional investors
Parkerburg, WV, March 13, 2023 (GLOBE NEWSWIRE) -- KronosMD, INC., a subsidiary of Kronos Advanced Technologies Inc (OTC MARKETS: KNOS) ("KNOS" or the "Company"), a leading product development and manufacturing company, announced today that KronosMD Inc., CEO Dr. Greg Rubin will attend the Roth Investor Conference March 13th - 14th.
Dr. Rubin will be available for meetings with investment bankers, retail investors and CEO's during the full term of the conference. To book a meeting with Dr. Rubin to discuss capital provisions, please email DrRubin/at/KronosMD.com directly for meeting times and contact details.
The conference will feature individual and small group meetings, industry panels, presentations and fireside chats with institutional investors, analysts, family offices and high net-worth investors.
For investors interested in learning more about KronosMD's innovative digital health technology and its potential for market disruption, Dr. Rubin's attendance at the Annual Roth Investor Conference provides an excellent opportunity for discussion and engagement. Investors can contact their Roth representative or KNOS investor relations team to coordinate meetings, either face-to-face during the conference or via an online virtual meeting in the weeks following.
The Annual Roth Conference is one of the largest investment conferences in the U.S. for small-cap companies. Roth Capital combines company presentations, Q&A sessions and management 1-on-1 meetings. Roth award-winning Research Team identifies distinguished presenting companies across broad sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more.
About KronosMD Inc.
As a transformative digital health company, KronosMD is revolutionizing the Healthcare industry by introducing patented SWAVE ™ ultrasound imaging technology in all dental care specialties, for any patient situation. The company’s innovations include the world's first point-of-care dental ultrasound system using an advanced, KronosMD acquired technology that is disrupting the dental imaging methodology by introducing ultrasound as an advanced clinical diagnostic and assessment tool, by making it portable, and economically appealing to the dental industry.
SWAVE™ sensor is the only 3D ultrasound transducer that can perform both extraoral and intraoral imaging in an ergonomical handheld probe using SWAVE™ technology. Our advanced technology will reduce the manufacturing cost, and our software platform will make the sensors easy to everyday use and will be fully integrated with the leading dental management and clinical workflow software and accessible on smartphones, or tablets.
Utilizing AI (Artificial Intelligence) and our proprietary and patented solutions, protected by an IP portfolio we will enable dentists to obtain more informed treatment decisions in real time without the need to take multiple X-Rays. In addition, SWAVE® provides an advanced ultrasound platform with
S-WAVE SCAN™ software that will be integrated into most dental practice management systems on the market.
We will manufacture and market the SWAVE™ system, which will include 3D Ultrasound sensors and accessories and software subscriptions (SaaS), to dental healthcare providers utilizing direct sales, and national distributors, via strategic partnerships and online sales.
About Kronos Advanced Technologies, Inc.
The Company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the Company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered, and sterilized. Historically, Kronos has focused on developing, marketing, and selling the Company's proprietary air movement and purification technology. Serving the Indoor Air Quality (IAQ) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes, and vehicles of all types -to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through our patented technology -replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft.
Kronos published research about the effectiveness of Kronos Patented technology on air disinfection n (e.g., microorganism destruction) by demonstrating the high efficacy of Kronos® Technology-based air purifiers in capturing and destruction of various types of microorganisms (including Corona Viruses) in different environmental settings back in 2008. Results of this research showed that Electrostatic Air Filtration and Purification systems based on Kronos technology demonstrated high capturing and destruction efficiency for different types of microorganisms, bacteria, and viruses, and can be successfully used for disinfection of air in real word environmental settings, including hospital facilities both with and without the presence of people.
BusinessWeek called Kronos air purifiers "VIRUS KILLER" in 2005.
Kronos is the first publicly traded company that accepts DOGE coin as a form of payment for its products, as well as other cryptocurrencies.
Recently, the Company filed for a provisional patent involving an innovative protective face mask with antimicrobial and anti-cellphone radiation protection features. The Company is planning to file additional patents to improve its existing technology as well as enter into new market segments but will continue to market air purifiers and other consumer products. The Company is an exclusive distributor and licensee of the latest generation of air purifiers based on the Company's CORE technologies. The Company markets its products as Airdog® and KRONOS® brands. All Kronos products come with Kronos Promise ™ -Your Satisfaction is Guaranteed!
Company offices are located in Parkersburg, West Virginia.
Shopping portal: https://www.1800safeair.com
Follow KNOS on Twitter: https://twitter.com/kronosati
Follow KNOS on Facebook: https://www.facebook.com/kronosati
Follow KNOS on Instagram: https://www.instagram.com/kronos_ati/
Follow KNOS on Youtube: https://www.youtube.com/channel/UCdtrQDt1R26Ulh8v-S-EpJg
Follow KNOS on Reddit: https://www.reddit.com/user/Kronos_ATI
Follow KNOS on LinkedIn: https://www.linkedin.com/company/kronos-advanced-techngologies-inc
Contact us via info@kronosati.co or visit https://www.kronosati.co or https://www.1800SafeAIR.com
Disclaimer
This news release does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Kronos Advanced Technologies Inc or any other third party regardless of whether such security, product, or service is referenced in this press release. Furthermore, nothing in this press release is intended to provide tax, legal, or investment advice, and nothing in it should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. Kronos Advanced Technologies does not represent that the securities, products, or services discussed in this press release are suitable for any particular investor. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You should consult your business advisor, attorney, and/or tax and accounting advisor regarding your specific business, legal, or tax situation.
Social Media Disclaimer and Forward-Looking Statements.
Kronos Advanced Technologies investors and others should note that we announce material information to the public about the Company through various means, including our website (https://www.kronosati.co/investors), press releases, OTCmarkets filings, public conference calls, via our corporate Social Media accounts, listed above.
We encourage our investors and others to monitor and review the information we make public in these locations, as such information could be deemed to be material information. Please note that this list may be updated from time to time.
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the OTC Markets at OTCMarkets.com. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products.
The forward-looking statements included in this press release represent the Company's views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
SOURCE: KRONOS ADVANCED TECHNOLOGIES, Inc
Phone inquiries: 1-800-SAFE-AIR (option #4)
FAQ
What is the purpose of Dr. Greg Rubin's attendance at the Roth Investor Conference?
When will the Roth Investor Conference take place?
How can investors meet with Dr. Greg Rubin during the conference?
What are the key features of KronosMD's SWAVE™ technology?
What type of investors will be present at the Roth Investor Conference?
Why is the Roth Investor Conference significant for small-cap companies?
